(Q48631776)

13 February 2018

title

Vasopressin antagonists block peripheral as well as central vasopressin receptors (English)

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(84)80101-X

3 August 2023

0 references

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(84)80101-X

3 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(84)80101-X

3 August 2023

author name string

D. De Wied

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6093152

3 August 2023

O. Gaffori

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6093152

3 August 2023

J. M. Van Ree

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6093152

3 August 2023

W. De Jong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6093152

3 August 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

13 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S009130578480101X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(84)80101-X

https://api.elsevier.com/content/article/PII:S009130578480101X?httpAccept=text/plain

3 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0091-3057(84)80101-X

Pharmacology, Biochemistry and Behavior

3 August 2023

published in

1 reference

13 February 2018

volume

21

1 reference

13 February 2018

page(s)

393-400

1 reference

13 February 2018

issue

3

1 reference

13 February 2018

Design of potent antagonists of the vasopressor response to arginine-vasopressin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Arginine-vasopressin binding sites in rat brain: A quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Effects of vasopressin on active and passive avoidance behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Oxytocin is a precursor of potent behaviourally active neuropeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent Neuropeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Long term effect of vasopressin on the maintenance of a conditioned avoidance response in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Long term and short term effects on retention of a conditioned avoidance response in rats by treatment with long acting pitressin and alpha-MSH.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Dissociation of the behavioural and endocrine effects of lysine vasopressin by tryptic digestion

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

[1-beta-Mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-methyl)tyrosine ]argine-vasopressin and [1-beta-mercapto-beta,beta-cyclopentamethylenepropionic acid)]argine-vasopressine, two highly potent antagonists of the vasopressor response t

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Vasopressor receptor antagonist prevents behavioural effects of vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Characterization of a uterine-type oxytocin receptor in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

The effects of ACTH- and vasopressin- analogues on CO2-induced retrograde amnesia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Neurohypophyseal principles and memory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Vasopressin and memory

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2884%2980101-X

7 January 2021

Identifiers

1 reference

13 February 2018

1 reference

13 February 2018